What This Site Is, and What It Isn't
A reading board publishing summaries of the BPC-157 research literature. Not a clinic. Not a vendor.
Publisher entity
BPC-157 Prescribed is a reading board for the published science on Body Protection Compound 157 (BPC-157): the peer-reviewed literature and the regulatory record, read together and summarized with citations. No clinic stands behind it and no clinician is on its masthead; it offers no medical guidance. It makes nothing and sells nothing. Its whole purpose is to lay out what the studies found and let the reader follow each citation to the source.
The domain name references both BPC-157's history in the U.S. prescription-compounding system and the continuing regulatory questions around the peptide. 'Prescribed' is an editorial frame that situates the reading board at the intersection of the research record and the compound's prescription history. It is not a claim about services this site provides, because this site provides none.
The modifier 'prescribed' in our domain name is editorial framing — a position the publisher occupies relative to the literature — not a claim that this site prescribes, facilitates prescriptions, or is affiliated with any clinical or pharmaceutical entity.
Editorial standards
Every claim on this site is sourced to a published, peer-reviewed study or a primary regulatory source. We use PubMed, PMC, NIH, ClinicalTrials.gov, peer-reviewed journals, and FDA regulatory documents. We do not cite preprints, conference abstracts, or unpublished data.
Quantitative claims — doses, half-lives, study counts, percentages, outcome statistics — are cited inline with reference numbers that link to the full citation on /references. We do not extrapolate or speculate beyond what the cited studies support.
We present the BPC-157 literature as it exists, including its limitations. The 2025 McGuire et al. independent narrative review — the first comprehensive review by authors not affiliated with the Zagreb research group — is cited throughout because it provides the most calibrated available synthesis of both the positive findings and the methodological limitations. We do not suppress inconvenient findings.
All dosage information is presented as research context — a record of what was studied in animal or human pilot settings, not as a basis for human administration decisions.
Disclaimer
BPC-157 is not approved for any human indication. FDA's safety-risk record places BPC-157 under 'nominated but withdrawn'; the withdrawal is not Category 1 status or compounding permission. U.S. patients may be considered for prescription care by a licensed U.S. clinician, who decides individually and can turn down a request; the options also depend on the state where the patient is seen and the specific treatment. A compounded BPC-157 preparation has no FDA approval. It is listed by WADA as a prohibited substance under S0 (Non-Approved Substances) for competitive athletes.
This board curates and summarizes the peer-reviewed research and the regulatory record. It does not offer medical advice. Nothing on this site should be construed as a recommendation for or against any particular course of action. Readers with health questions should consult a licensed healthcare provider.
This is a literature digest. Not a clinic, not a vendor, not a prescription.